High performance liquid chromatography–high resolution mass spectrometry and micropulverized extraction for the quantification of amphetamines, cocaine, opioids, benzodiazepines, antidepressants and hallucinogens in 2.5mg hair samples-Reference-Cited by-同舟云学术

High performance liquid chromatography–high resolution mass spectrometry and micropulverized extraction for the quantification of amphetamines, cocaine, opioids, benzodiazepines, antidepressants and hallucinogens in 2.5mg hair samples

Published:2011-09 Issue:38 Volume:1218 Page:6583-6595
ISSN:0021-9673
Container-title:Journal of Chromatography A
language:en
Short-container-title:Journal of Chromatography A

Author:

Favretto Donata,Vogliardi Susanna,Stocchero Giulia,Nalesso Alessandro,Tucci Marianna,Ferrara Santo Davide

Publisher

Elsevier BV

Subject

Organic Chemistry,General Medicine,Biochemistry,Analytical Chemistry

Reference57 articles.

1. State of the art in hair analysis for detection of drug and alcohol abuse

2. Hair Analysis for Drug Detection

3. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations

4. The role of alternative specimens in toxicological analysis

5. Recommendations for hair testing in forensic cases

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electromembrane extraction of drugs of abuse and prescription drugs from micropulverized hair;Journal of Analytical Toxicology;2024-06-11

2. Infant exposure to drugs of abuse investigated by hair analysis;Drug Testing and Analysis;2024-03-16

3. Hair toxicological analysis of infants and their mothers: a 5-year retrospective study focusing on cocaine;International Journal of Legal Medicine;2024-02-24

4. Recent Update on Pretreatment and Analysis Methods of Buprenorphine in Different Matrix;Critical Reviews in Analytical Chemistry;2022-08-18

5. Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches?;Current Pharmaceutical Design;2022-05